Clinical Trial Update: A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral tebipenem pivoxil hydrobromide to intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis

Drugs mentioned

• Imipenem/Cilastatin (imipenem/cilastatin)
• Tebipenem-pivoxil-hydrobromide (tebipenem pivoxil hydrobromide)

Snippet

Sponsor: Spero Therapeutics | Conditions: Urinary Tract Infection, Acute Pyelonephritis | Phase 3 | Status: COMPLETED | Results posted: 2026-03-10